09.06.2013 Views

Complementary Alternative Cardiovascular Medicine

Complementary Alternative Cardiovascular Medicine

Complementary Alternative Cardiovascular Medicine

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

14 <strong>Alternative</strong> <strong>Cardiovascular</strong> <strong>Medicine</strong><br />

one-third of the world’s population. However, the best accepted forms<br />

of herbal therapy today are those that are supported by modern clinical<br />

research, usually involving semipurified, standardized extracts of single<br />

herbs or simple combinations of fewer than six herbs, in contrast to the<br />

complex mixtures characteristic of TCM remedies. The highest quality<br />

research is on single-herb extracts, such as ginkgo, St. John’s wort, and<br />

saw palmetto.<br />

GOVERNMENT REGULATION OF HERBAL PRODUCTS<br />

Although many believe that herbal medicine was displaced by safer<br />

or more effective medicines, the truth is that synthetics overtook natural<br />

medicines in the pharmacy because of economics and regulation, not<br />

science and medicine. In the early 20th century, the US Congress,<br />

alarmed by questionable “patent medicines,” established the Food and<br />

Drug Administration (FDA) and required foods and drugs to be proven<br />

safe before they could be sold. As more sophisticated and expensive<br />

research methods were devised, it became increasingly expensive to<br />

establish the safety of drugs. In 1962, Congress passed the additional<br />

requirement that drugs be proven effective, further increasing the cost of<br />

drug approval. Drug industry statistics set the cost at an average of $350<br />

million to prove that a drug is safe and effective, and it can take 5–12 yr<br />

or more to gain approval. Drug companies can recover research and<br />

approval costs through the sale of the drug but only if the company has<br />

the exclusive right to sell it. However, herbal medicines are rarely patentable,<br />

denying companies the exclusive right to sell them. Patent law<br />

prevents people from claiming that they invented substances or technologies<br />

that were already known. Common substances such as ice or<br />

ginseng, have been known for too long to be patentable. If a company<br />

choses to spend $350 million to prove that ginseng is safe and effective,<br />

anyone could sell it as a safe and effective drug. The effect of regulation<br />

and economics on plant-based pharmaceuticals has been chilling. Since<br />

1962, not a single new complex plant drug has been approved in the<br />

United States. Because herbs could not be sold as medicines, they were<br />

regulated as foods or occasionally as food chemicals (additives). Today,<br />

herbs, as well as vitamins and minerals, are regulated as dietary supplements<br />

in the United States.<br />

The Introduction of DSHEA<br />

The relationship between the FDA and the American herb industry<br />

has been highly adversarial for the past 30 yr. In 1994, the US Congress<br />

unanimously passed a bill called the Dietary Supplement Health and<br />

Education Act (DSHEA), which defined dietary supplements as special

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!